Chaikin Analytics notes that Natera (NTRA) has jumped roughly 25% since its personalized cancer test received a gold standard endorsement from the NCCN.

Public source

Publisher name

Public post

Natera (NTRA) has jumped roughly 25% since its personalized cancer test received a “gold standard” endorsement from the NCCN. And adoption is accelerating. Cancer-testin…

Log in to read the full post

Company

Chaikin Analytics

Smarter Stock Selection - and Options and ETFs

Industry
Financial Services
Location
Baltimore, US
Company size
11–50 employees

About Chaikin Analytics

Chaikin Analytics is an award-winning approach to stock & ETF selection.

See more

Latest activity

2 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.